To commemorate The Regulatory Review’s 10th anniversary, leading scholars and practitioners reflect on regulation’s past, present, and future.
The Regulatory Review presents its leading essays from the past year.
FDA ought to promote stem cell therapy by easing up on regulation and its aggressive enforcement.
Human agency is at the center of the solution to fix the government and the civil service.
The Supreme Court’s recent Weyerhaeuser decision will add to the administrative costs of protecting endangered species.
Commentators highlight the ramifications of the Court’s most significant regulatory cases.
Much support for government deregulation originates from left-wing thought.
President Trump’s deregulation efforts have resulted in fewer career experts at regulatory agencies.
Presidents Reagan and Trump differ on approaches to social and economic regulation.
Some of President Trump’s deregulatory actions are innovations, others build on his predecessors’ work.
The history of regulatory policy in the United States is rich, but its future remains unclear.
Leading scholars compare deregulation under the Reagan and Trump Administrations.